Lv4
475 积分 2021-07-21 加入
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
2天前
已完结
Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction–associated fatty liver disease: Results from two prospective cohorts
7天前
已完结
MASLD and non-liver-related mortality: association, independent association and causality
13天前
已完结
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
1个月前
已完结
Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities
1个月前
已完结
Plasma FSTL-1 as a non-invasive diagnostic biomarker for patients with advanced liver fibrosis
1个月前
已关闭
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
1个月前
已完结
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
1个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management
Framework materials for supercapacitors
皖公网安备34019202002308
